Soluble ST2 Plasma Concentrations Predict Mortality in HBV-Related Acute-on-Chronic Liver Failure

Figure 1

Baseline plasma levels of IL-33 and soluble ST2 (sST2). Individual data points represent mean values of patients with hepatitis B-related acute-on-chronic liver failure (HBV-ACLF,  ), patients with chronic hepatitis B (CHB,  ), and healthy controls (HC,  ). Horizontal lines indicate median values of each group. (a) Baseline plasma levels of IL-33 were determined using Luminex xMAP technology. (b) Baseline plasma sST2 levels were determined by ELISA. Differences between two groups were evaluated using the Mann-Whitney test.

(a)

(b)